Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07493850
Brief Summary:
The goal of this clinical study is to evaluate the efficacy and tolerability of EMC-CAP-2025A, an eggshell membrane-based dietary supplement, on age-related skin parameters in healthy adults.
The main questions this study aims to answer are:
* Does daily supplementation with EMC-CAP-2025A improve facial wrinkles compared to placebo?
* Does EMC-CAP-2025A improve skin hydration, firmness, elasticity, texture, and overall skin quality?
* Is EMC-CAP-2025A well tolerated when taken daily for 60 days?
Researchers will compare EMC-CAP-2025A to a placebo to assess its effects on multiple skin parameters using objective instrumental assessments and participant self-evaluations.
Participants will:
* Be randomly assigned to receive either EMC-CAP-2025A or a placebo
* Take one capsule orally once daily for 60 days
* Attend scheduled study visits at baseline, Day 30, and Day 60 for instrumental skin assessments and safety evaluations
* Complete self-assessment questionnaires related to skin quality and product tolerability
Study:
NCT07493850
Study Brief:
Protocol Section:
NCT07493850